Semaglutide has emerged as a groundbreaking treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to release more insulin and reducing https://emiliagiwz432427.fitnell.com/76477500/understanding-semaglutide-a-comprehensive-guide